Code | 7929D | ||||||||||
MA number | 44/0185/21-S | ||||||||||
Product Form: | tbl flm 120x1x250 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 23.07.2021 |
Validity: | 23.07.2026 |
PIL: | PIL_Abiraterón Sandoz 250 mg_500 mg tbl flm_jún 2021.pdf |
SPC: | SPC_Abiraterón Sandoz 250 mg_500 mg tbl flm_jún 2021.pdf |
Safety feature | Yes |
Data update: | 02.08.2021 |